Average Co-Inventor Count = 4.39
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Biotech, Inc. (9 from 410 patents)
2. Centocor, Inc. (3 from 144 patents)
3. Other (2 from 832,880 patents)
4. Karen Duffy (0 patent)
5. Vedrana Stojanovic-susulic (0 patent)
6. Theresa J. Goletz (0 patent)
7. Shizhong Chen (0 patent)
8. Raymond Sweet (0 patent)
9. Kristen Picha (0 patent)
10. Mouhamadou L. Mbow (0 patent)
11. Gopalan Raghunathan (0 patent)
12. Jill Giles-komar (0 patent)
13. Robert T. Sarisky (0 patent)
14. Nicole Stowell (0 patent)
15. Roberta Lamb (0 patent)
14 patents:
1. 12304939 - EGFR and C-met fibronectin type III domain binding molecules
2. 10954284 - EGFR and c-Met fibronectin type III domain binding molecules
3. 10662235 - Cysteine engineered fibronectin type III domain binding molecules
4. 9725497 - EGFR and C-Met fibronectin type III domain binding molecules
5. 9695228 - EGFR and c-Met fibronectin type III domain binding molecules
6. 8906649 - Antibodies binding human collagen II
7. 8883447 - Anti-GLP-1R antibodies and their uses
8. 8394378 - Antibodies binding human collagen II
9. 8389689 - Anti-GLP-1R antibodies and their uses
10. 8153583 - Toll like receptor 3 antagonists, methods and uses
11. 8071103 - Pharmaceutical composition comprising a human GLP-1 mimetibody
12. 8043616 - sRAGE mimetibody, compositions, methods and uses
13. 7833531 - Method for treating insulin sensitivity by long-acting GLP-1 receptor mimetibody agonists
14. 7812121 - GLP-2 mimetibodies, polypeptides, compositions, methods and uses